Myomo (MYO) Amortization of Deferred Charges (2020 - 2021)
Myomo posted quarterly Amortization of Deferred Charges of -$99947.0 for Q2 2021, down 349.87% year-on-year from $40000.0 in Q2 2020, and down 159.99% on a QoQ basis from $166600.0 in Q1 2021.
Myomo (MYO) has 2 years of Amortization of Deferred Charges data on file, last reported at -$99947.0 in Q2 2021.
- For the quarter ending Q2 2021, Amortization of Deferred Charges fell 349.87% year-over-year to -$99947.0; the trailing twelve-month figure through Jun 2021 stood at $78753.0 (down 26.49% YoY), and the FY2020 full-year result was $161869.0, up 177.67% from the prior year.
- Amortization of Deferred Charges for Q2 2021 stood at -$99947.0, down from $166600.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $166600.0 in Q1 2021 and bottomed at -$99947.0 in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -99,947.00 |
| Jun 30, 2021 | -99,947.00 |
| Mar 31, 2021 | 166,600.00 |
| Mar 31, 2021 | 166,600.00 |
| Sep 30, 2020 | 12,100.00 |
| Sep 30, 2020 | 12,100.00 |
| Jun 30, 2020 | 40,000.00 |
| Jun 30, 2020 | 40,000.00 |
| Mar 31, 2020 | 67,132.00 |
| Mar 31, 2020 | 67,132.00 |